Nephros Inc (NEPH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nephros Inc (NEPH) has a cash flow conversion efficiency ratio of 0.023x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($230.00K) by net assets ($10.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nephros Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Nephros Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Nephros Inc for a breakdown of total debt and financial obligations.
Nephros Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nephros Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XPLUS SA ZY -01
F:75R
|
N/A |
|
Grace Therapeutics, Inc.
NASDAQ:GRCE
|
-0.050x |
|
Ashima Limited
NSE:ASHIMASYN
|
0.004x |
|
Zanaga Iron Ore Company Limited
F:6ZA
|
0.001x |
|
OneMedNet Corp.
NASDAQ:ONMD
|
0.396x |
|
Memscap Regpt
PA:MEMS
|
0.048x |
|
Bukit Darmo Property Tbk
JK:BKDP
|
-0.020x |
|
Big 5 Sporting Goods Corporation
NASDAQ:BGFV
|
-0.258x |
Annual Cash Flow Conversion Efficiency for Nephros Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Nephros Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see NEPH company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $10.20 Million | $1.65 Million | 0.161x | +381.36% |
| 2024-12-31 | $8.59 Million | $-492.00K | -0.057x | -157.92% |
| 2023-12-31 | $8.36 Million | $827.00K | 0.099x | +127.17% |
| 2022-12-31 | $8.88 Million | $-3.23 Million | -0.364x | -279.03% |
| 2021-12-31 | $14.75 Million | $-1.42 Million | -0.096x | +78.33% |
| 2020-12-31 | $15.57 Million | $-6.90 Million | -0.443x | -49.75% |
| 2019-12-31 | $7.69 Million | $-2.28 Million | -0.296x | +45.05% |
| 2018-12-31 | $6.80 Million | $-3.66 Million | -0.539x | -1264.21% |
| 2017-12-31 | $1.95 Million | $-77.00K | -0.039x | +98.75% |
| 2016-12-31 | $667.00K | $-2.11 Million | -3.166x | -121.11% |
| 2015-12-31 | $2.66 Million | $-3.81 Million | -1.432x | -426.07% |
| 2014-12-31 | $-5.68 Million | $-2.50 Million | 0.439x | -92.52% |
| 2013-12-31 | $-610.00K | $-3.58 Million | 5.874x | +125.91% |
| 2012-12-31 | $-595.00K | $-1.55 Million | 2.600x | +385.08% |
| 2011-12-31 | $1.42 Million | $-1.30 Million | -0.912x | +90.47% |
| 2010-12-31 | $135.00K | $-1.29 Million | -9.570x | -617.41% |
| 2009-12-31 | $1.96 Million | $-2.61 Million | -1.334x | +40.95% |
| 2008-12-31 | $2.53 Million | $-5.72 Million | -2.259x | -166.10% |
| 2007-12-31 | $8.76 Million | $-7.43 Million | -0.849x | -124.38% |
| 2006-12-31 | $-2.10 Million | $-7.30 Million | 3.482x | +470.79% |
| 2005-12-31 | $5.38 Million | $-5.05 Million | -0.939x | -15.62% |
| 2004-12-31 | $9.65 Million | $-7.84 Million | -0.812x | -228.14% |
| 2003-12-31 | $-5.38 Million | $-3.41 Million | 0.634x | +180.58% |
| 2002-12-31 | $-8.00 Million | $-1.81 Million | 0.226x | -- |
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and p… Read more